史晶洁,等·人乳头瘤病毒样颗粒组装研究进展 2160-2167 [31] Hanslip S J, Zaccai N R, Middelberg A P, Falconer R [25] Ishii Y, Tanaka K, Kanda T. Mutational analysis of J. Assembly of human papillomavirus type-16 virus- human papillomavirus type 16 major capsid like particles: Multifactorial study of assembly and The cysteines affecting the intermolecular bonding and competing aggregation[J]. Biotechnol Prog, 2006,22 structure of LI-capsidsDJJ. Virology, 2003, 308(1): (2):554-560. 128-136. [32] Mukherjee S, Thorsteinsson M V, Johnston LB, De- [26] Shi L, Sanyal G, Luo Z, Ni A, Doshna S, Wang B, Phillips P A, Zlotnick A. A quantitative description of Graham T L, Wang N, Volkin D B. Stabilization of in vitro assembly of human papillomavirus 16 virus-like human papillomavirus virus-like particles by nonionic particles[J]. J Mol Biol, 2008, 381(1):229-237. surfactants[J]. J Pharm Sci, 2005, 94(7): 1538-1551. [33] Kirnbauer R. Taub J, Greenstone H,, Roden R. [27] Katakam M, Bell LN, Banga A K. Effect of surfac- Durst M, Gissmann L, Lowy D R, Schiller J T. Effi- tants on the physical stability of recombinant human cient self-assembly of human papillomavirus type 16 L1 growth hormone[J]. J Pharm Sci,1995,84(6):713- and L1-L2 into virus-like particles[J]. J Virol,1993 716 67(12):6929-6936 [28] Bam N B, Randolph T W, Cleland J L. Stability of [34] Ishii Y, Ozaki S, Tanaka K, Kanda T. Human papi- protein formulations: Investigation of surfactant lomavirus 16 minor capsid protein L2 helps capsomeres effects by a novel epr spectroscopic technique [J] assemble independently of intercapsomeric disulfide Pharm res,1995,12(1):2-11 bonding[J]. Virus Genes, 2005,31(3):321-328 [29] Arakawa T, Kita Y. Protection of bovine serum albu-[35]赵朴,郑玉姝,刘兴友.病毒样颗粒疫苗及载体的研究 min from aggregation by Tween 80[J]. J Pharm Sci 进展[J.中国生物制品学杂志,2009,22(5):515 000,89(5):646-651 [30] McCarthy M P, White W I, Palmer-Hill F, Koenig S, [36] Kanda T, Kondo K. Development of an HPV vaccine Suzich J A. Quantitative disassembly and reassembly for a broad spectrum of high-risk types[J]. Hum Vac- of human papillomavirus type 1l viruslike particles in cin,2009,5(1):43-45 vitro[J]. J Virol,1998,72(1):32-41 21994-2018ChinaAcademicJOurnalElectronicpUblishingHouse.Allrightsreservedhttp:/www.cnki.net２１６０－２１６７． ［２５］ＩｓｈｉｉＹ，ＴａｎａｋａＫ，ＫａｎｄａＴ．Ｍｕｔａｔｉｏｎａｌａｎａｌｙｓｉｓｏｆ ｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓｔｙｐｅ１６ｍａｊｏｒｃａｐｓｉｄｐｒｏｔｅｉｎＬ１： Ｔｈｅｃｙｓｔｅｉｎｅｓａｆｆｅｃｔｉｎｇｔｈｅｉｎｔｅｒｍｏｌｅｃｕｌａｒｂｏｎｄｉｎｇａｎｄ ｓｔｒｕｃｔｕｒｅｏｆＬ１－ｃａｐｓｉｄｓ［Ｊ］．Ｖｉｒｏｌｏｇｙ，２００３，３０８（１）： １２８－１３６． ［２６］ＳｈｉＬ，ＳａｎｙａｌＧ，ＬｕｏＺ，ＮｉＡ，ＤｏｓｈｎａＳ，ＷａｎｇＢ， ＧｒａｈａｍＴ Ｌ，Ｗａｎｇ Ｎ，ＶｏｌｋｉｎＤ Ｂ．Ｓｔａｂｉｌｉｚａｔｉｏｎｏｆ ｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓｖｉｒｕｓ－ｌｉｋｅｐａｒｔｉｃｌｅｓｂｙｎｏｎ－ｉｏｎｉｃ ｓｕｒｆａｃｔａｎｔｓ［Ｊ］．ＪＰｈａｒｍＳｃｉ，２００５，９４（７）：１５３８－１５５１． ［２７］Ｋａｔａｋａｍ Ｍ，ＢｅｌｌＬＮ，ＢａｎｇａＡ Ｋ．Ｅｆｆｅｃｔｏｆｓｕｒｆａｃ－ ｔａｎｔｓｏｎｔｈｅｐｈｙｓｉｃａｌｓｔａｂｉｌｉｔｙｏｆｒｅｃｏｍｂｉｎａｎｔｈｕｍａｎ ｇｒｏｗｔｈｈｏｒｍｏｎｅ［Ｊ］．ＪＰｈａｒｍＳｃｉ，１９９５，８４（６）：７１３－ ７１６． ［２８］Ｂａｍ Ｎ Ｂ，ＲａｎｄｏｌｐｈＴ Ｗ，ＣｌｅｌａｎｄＪＬ．Ｓｔａｂｉｌｉｔｙｏｆ ｐｒｏｔｅｉｎ ｆｏｒｍｕｌａｔｉｏｎｓ： Ｉｎｖｅｓｔｉｇａｔｉｏｎ ｏｆ ｓｕｒｆａｃｔａｎｔ ｅｆｆｅｃｔｓｂｙａ ｎｏｖｅｌｅｐｒｓｐｅｃｔｒｏｓｃｏｐｉｃｔｅｃｈｎｉｑｕｅ［Ｊ］． ＰｈａｒｍＲｅｓ，１９９５，１２（１）：２－１１． ［２９］ＡｒａｋａｗａＴ，ＫｉｔａＹ．Ｐｒｏｔｅｃｔｉｏｎｏｆｂｏｖｉｎｅｓｅｒｕｍａｌｂｕ－ ｍｉｎｆｒｏｍａｇｇｒｅｇａｔｉｏｎｂｙＴｗｅｅｎ８０［Ｊ］．ＪＰｈａｒｍＳｃｉ， ２０００，８９（５）：６４６－６５１． ［３０］ＭｃＣａｒｔｈｙＭＰ，ＷｈｉｔｅＷＩ，Ｐａｌｍｅｒ－ＨｉｌｌＦ，ＫｏｅｎｉｇＳ， ＳｕｚｉｃｈＪＡ．Ｑｕａｎｔｉｔａｔｉｖｅｄｉｓａｓｓｅｍｂｌｙａｎｄｒｅａｓｓｅｍｂｌｙ ｏｆｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓｔｙｐｅ１１ｖｉｒｕｓｌｉｋｅｐａｒｔｉｃｌｅｓｉｎ ｖｉｔｒｏ［Ｊ］．ＪＶｉｒｏｌ，１９９８，７２（１）：３２－４１． ［３１］ＨａｎｓｌｉｐＳＪ，ＺａｃｃａｉＮＲ，ＭｉｄｄｅｌｂｅｒｇＡＰ，ＦａｌｃｏｎｅｒＲ Ｊ．Ａｓｓｅｍｂｌｙｏｆｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓｔｙｐｅ－１６ｖｉｒｕｓ－ ｌｉｋｅｐａｒｔｉｃｌｅｓ： Ｍｕｌｔｉｆａｃｔｏｒｉａｌｓｔｕｄｙ ｏｆａｓｓｅｍｂｌｙ ａｎｄ ｃｏｍｐｅｔｉｎｇａｇｇｒｅｇａｔｉｏｎ［Ｊ］．ＢｉｏｔｅｃｈｎｏｌＰｒｏｇ，２００６，２２ （２）：５５４－５６０． ［３２］ＭｕｋｈｅｒｊｅｅＳ，ＴｈｏｒｓｔｅｉｎｓｓｏｎＭ Ｖ，ＪｏｈｎｓｔｏｎＬＢ，Ｄｅ－ ＰｈｉｌｌｉｐｓＰＡ，ＺｌｏｔｎｉｃｋＡ．Ａｑｕａｎｔｉｔａｔｉｖｅｄｅｓｃｒｉｐｔｉｏｎｏｆ ｉｎｖｉｔｒｏａｓｓｅｍｂｌｙｏｆｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓ１６ｖｉｒｕｓ－ｌｉｋｅ ｐａｒｔｉｃｌｅｓ［Ｊ］．ＪＭｏｌＢｉｏｌ，２００８，３８１（１）：２２９－２３７． ［３３］ＫｉｒｎｂａｕｅｒＲ，ＴａｕｂＪ，Ｇｒｅｅｎｓｔｏｎｅ Ｈ，，Ｒｏｄｅｎ Ｒ， ＤüｒｓｔＭ，ＧｉｓｓｍａｎｎＬ，ＬｏｗｙＤＲ，ＳｃｈｉｌｌｅｒＪＴ．Ｅｆｆｉ－ ｃｉｅｎｔｓｅｌｆ－ａｓｓｅｍｂｌｙｏｆｈｕｍａｎｐａｐｉｌｌｏｍａｖｉｒｕｓｔｙｐｅ１６Ｌ１ ａｎｄＬ１－Ｌ２ｉｎｔｏｖｉｒｕｓ－ｌｉｋｅｐａｒｔｉｃｌｅｓ［Ｊ］．ＪＶｉｒｏｌ，１９９３， ６７（１２）：６９２９－６９３６． ［３４］ＩｓｈｉｉＹ，ＯｚａｋｉＳ，ＴａｎａｋａＫ，ＫａｎｄａＴ．Ｈｕｍａｎｐａｐｉｌ－ ｌｏｍａｖｉｒｕｓ１６ｍｉｎｏｒｃａｐｓｉｄｐｒｏｔｅｉｎＬ２ｈｅｌｐｓｃａｐｓｏｍｅｒｅｓ ａｓｓｅｍｂｌｅｉｎｄｅｐｅｎｄｅｎｔｌｙ ｏｆｉｎｔｅｒｃａｐｓｏｍｅｒｉｃ ｄｉｓｕｌｆｉｄｅ ｂｏｎｄｉｎｇ［Ｊ］．ＶｉｒｕｓＧｅｎｅｓ，２００５，３１（３）：３２１－３２８． ［３５］赵朴，郑玉 姝，刘 兴 友．病毒样颗粒疫苗及载体的研 究 进展［Ｊ］．中国生物制品学杂志，２００９，２２（５）：５１５－ ５１７． ［３６］ＫａｎｄａＴ，ＫｏｎｄｏＫ．Ｄｅｖｅｌｏｐｍｅｎｔｏｆａｎ ＨＰＶｖａｃｃｉｎｅ ｆｏｒａｂｒｏａｄｓｐｅｃｔｒｕｍｏｆｈｉｇｈ－ｒｉｓｋｔｙｐｅｓ［Ｊ］．ＨｕｍＶａｃ－ ｃｉｎ，２００９，５（１）：４３－４５． ２期 史晶洁，等．人乳头瘤病毒样颗粒组装研究进展 · ７５２ ·